Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
While there is no known therapy for actually de-aging any organ, including skin, the peptide is thought to exert possible cosmetic benefits on skin that warrant research
In-person visits create opportunities for practitioners to address injection site concerns, discuss dietary modifications that complement semaglutide therapy, and manage any medication side effects in real time
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials